[HTML] springer.com

[HTML][HTML] Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of Molecular …, 2019 - Springer
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …
被引用次数：14 相关文章
[HTML] nih.gov

[HTML][HTML] Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of Molecular …, 2019 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of Molecular …, 2019 - infona.pl
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of …, 2019 - search.proquest.com
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.

PR Gajjala, H Bruck, H Noels… - Journal of …, 2019 - search.ebscohost.com
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of Molecular …, 2019 - europepmc.org
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, J Sáez Rodríguez - 2019 - katalog.ub.uni-heidelberg.de
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels… - Journal of …, 2019 - cris.maastrichtuniversity.nl
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …
[PDF] d-nb.info

[PDF][PDF] Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

PR Gajjala, H Bruck, H Noels, G Heinze… - Journal of Molecular …, 2019 - d-nb.info
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …